{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:28:24Z","timestamp":1787149704286,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"name":"the Capital Health Development Research Project","award":["2026-2-4036"],"award-info":[{"award-number":["2026-2-4036"]}]},{"name":"the National High Level Hospital Clinical Research Funding","award":["2024-GSP-TJ-8"],"award-info":[{"award-number":["2024-GSP-TJ-8"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-C&T-B-061"],"award-info":[{"award-number":["2023-I2M-C&T-B-061"]}]},{"name":"the Special Project of \u00e2\u20ac\u0153Science & Technology Deputy Director\u00e2\u20ac\u009d in Changping District","award":["T2025-ZX057"],"award-info":[{"award-number":["T2025-ZX057"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-1-002"],"award-info":[{"award-number":["2023-I2M-1-002"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Insulin resistance and systemic inflammation are key drivers of atherosclerosis but are typically evaluated separately. This study aimed to determine whether integrating the triglyceride-glucose (TyG) index with inflammatory markers improves long-term risk stratification for major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this prospective cohort study, 9316 CAD patients were followed for 10 years. Cox regression models were used to assess associations between the TyG index and inflammatory markers with MACE. Incremental predictive value was evaluated using net reclassification improvement (NRI) and integrated discrimination improvement. The combined TyG-inflammation models were significantly associated with an increased risk of 10-year MACE, corresponding to a 19.1% relative increase in hazard. Among the evaluated models, the TyG + systemic inflammation response index (SIRI) combination demonstrated the most consistent performance, primarily through improving risk reclassification rather than discrimination. The model achieved an NRI of 5.5% for overall MACE and 15.4% for cardiac death, indicating improved identification of high-risk patients who would not be detected by the TyG index alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integrating systemic inflammation, particularly SIRI, with the TyG index significantly enhances long-term cardiovascular risk reclassification in CAD patients. This simple and cost-effective approach based on routine laboratory parameters may improve risk stratification and support more targeted secondary prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001665","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:01:11Z","timestamp":1787148071000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Combined triglyceride-glucose index and systemic inflammation for long-term risk stratification in major adverse cardiovascular events: a 10-year prospective study"],"prefix":"10.1097","author":[{"given":"Zhao","family":"Ma","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sida","family":"Jia","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Queyun","family":"Sun","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Gao","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"R1-20260819","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance.","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"R2-20260819","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.3390\/jcm11154358","article-title":"Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases.","volume":"11","author":"Puschel","year":"2022","journal-title":"J Clin Med"},{"key":"R3-20260819","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2478\/jtim-2024-0006","article-title":"Comparison of admission glycemic variability and glycosylated hemoglobin in predicting major adverse cardiac events among type 2 diabetes patients with heart failure following acute ST-segment elevation myocardial infarction.","volume":"12","author":"Yang","year":"2024","journal-title":"J Transl Int Med"},{"key":"R4-20260819","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12933-023-01906-4","article-title":"Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis.","volume":"22","author":"Liang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R5-20260819","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations.","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R6-20260819","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis.","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"R7-20260819","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jacc.2019.07.061","article-title":"From focal lipid storage to systemic inflammation: JACC review topic of the week.","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R8-20260819","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/cvr\/cvac126","article-title":"SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation.","volume":"119","author":"Liberale","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R9-20260819","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis.","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"R10-20260819","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R11-20260819","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction.","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"R12-20260819","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/JIR.S454117","article-title":"Correlations between acute coronary syndrome and novel inflammatory markers (systemic immune-inflammation index, systemic inflammation response index, and aggregate index of systemic inflammation) in patients with and without diabetes or prediabetes.","volume":"17","author":"Tuzimek","year":"2024","journal-title":"J Inflamm Res"},{"key":"R13-20260819","doi-asserted-by":"crossref","first-page":"1415484","DOI":"10.3389\/fnut.2024.1415484","article-title":"Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007-2018.","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"R14-20260819","doi-asserted-by":"crossref","first-page":"2536204","DOI":"10.1080\/07853890.2025.2536204","article-title":"Integrated machine learning and population attributable fraction analysis of systemic inflammatory indices for mortality risk prediction in diabetes and prediabetes.","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann Med"},{"key":"R15-20260819","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12944-020-1187-0","article-title":"Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors.","volume":"19","author":"Park","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R16-20260819","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12933-022-01576-8","article-title":"Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.","volume":"21","author":"Wu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R17-20260819","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12933-023-01780-0","article-title":"Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome.","volume":"22","author":"Xiong","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R18-20260819","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-021-01332-4","article-title":"Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.","volume":"20","author":"Zhu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"R19-20260819","doi-asserted-by":"crossref","first-page":"10760296221146183","DOI":"10.1177\/10760296221146183","article-title":"The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"28","author":"Fan","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"R20-20260819","doi-asserted-by":"crossref","first-page":"1248655","DOI":"10.3389\/fcvm.2023.1248655","article-title":"Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction.","volume":"10","author":"Wei","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R21-20260819","doi-asserted-by":"crossref","first-page":"1367919","DOI":"10.3389\/fcvm.2024.1367919","article-title":"Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries.","volume":"11","author":"Zhou","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R22-20260819","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/07853890.2022.2083671","article-title":"Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"54","author":"Han","year":"2022","journal-title":"Ann Med"},{"key":"R23-20260819","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.2147\/JIR.S482596","article-title":"Prognostic value of systemic inflammation response index and N-Terminal Pro-B-Type natriuretic peptide in patients with myocardial infarction with nonobstructive coronary arteries \u2013 a retrospective study.","volume":"17","author":"Hou","year":"2024","journal-title":"J Inflamm Res"},{"key":"R24-20260819","doi-asserted-by":"crossref","first-page":"811790","DOI":"10.3389\/fcvm.2022.811790","article-title":"Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients.","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R25-20260819","doi-asserted-by":"crossref","first-page":"18083","DOI":"10.1038\/s41598-024-69158-0","article-title":"The effect of hsCRP on TyG index-associated cardiovascular risk in patients with acute coronary syndrome undergoing PCI.","volume":"14","author":"Ma","year":"2024","journal-title":"Sci Rep"},{"key":"R26-20260819","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.3390\/nu15122808","article-title":"Inflammation and insulin resistance in diabetic chronic coronary syndrome patients.","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"R27-20260819","doi-asserted-by":"crossref","first-page":"e70150","DOI":"10.1111\/eci.70150","article-title":"The conservativeness of standard C statistics in the prediction of clinical events.","volume":"56","author":"Zoccali","year":"2026","journal-title":"Eur J Clin Invest"},{"key":"R28-20260819","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models.","volume":"176","author":"Pencina","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R29-20260819","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R30-20260819","first-page":"1094","article-title":"Arterial stiffness mediates insulin resistance-related risk of atherosclerotic cardiovascular disease: a real-life, prospective cohort study.","volume":"33","author":"Wu","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"R31-20260819","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11883-025-01331-w","article-title":"Novel strategies to conquer residual adiposity risk in cardiovascular disease.","volume":"27","author":"Philip","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"R32-20260819","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2478\/jtim-2022-0012","article-title":"Inflammatory factors driving atherosclerotic plaque progression new insights.","volume":"10","author":"Song","year":"2022","journal-title":"J Transl Int Med"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:01:16Z","timestamp":1787148076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001665","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"2026-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}